NMPA Approval

Rifaximin Tablets

Approval Number

国药准字HJ20181212

Registration Date

June 7, 2023

Previous Approval Numbers

H20181212

Drug Information

Generic Name

利福昔明片

Trade Name

昔服申

Dosage Form

片剂

Strength

0.2g

Drug Type

化学药品

Registration Date

June 7, 2023

Expiry Date

June 6, 2028

Company Address

VIA RAGAZZI DEL＇99,5-40133 BOLOGNA, Italy

Company Address

VIA ENRICO FERMI,1-65020 ALANNO (PE), Italy

Empowering clinical research with data-driven insights and AI-powered tools.

利福昔明片 - NMPA 批准文号 | MedPath